[Prevention of perinatal group B streptococcal disease. Spanish revised guidelines. The Spanish Society of Obstetrics and Gynecology, The Spanish Society of Neonatology, The Spanish Society of Infectious Diseases and Clinical Microbiology, The Spanish Society of Chemotherapy, and the The Spanish Society of Family and Community Medicine].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State; D002821:Chorioamnionitis / Q000188:drug therapy / Q000382:microbiology; D036861:Delivery, Obstetric; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000382:microbiology; D011292:Premedication; D013290:Streptococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D013292:Streptococcus agalactiae; D016585:Vaginosis, Bacterial / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents